UniProtKB/Swiss-Prot Q9BXM7 : Variant p.Cys125Gly
Serine/threonine-protein kinase PINK1, mitochondrial
Gene: PINK1
Feedback ?
Variant information
Variant position:
125
The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:
LP/P [Disclaimer : Variants classification is intended for research purposes only, not for clinical and diagnostic use . The label disease variant is assigned according to literature reports on probable disease-association that can be based on theoretical reasons. This label must not be considered as a definitive proof for the pathogenic role of a variant. ]
The variants are classified into three categories: LP/P, LB/B and US.LP/P: likely pathogenic or pathogenic. LB/B: likely benign or benign. US: uncertain significance
Residue change:
From Cysteine (C) to Glycine (G) at position 125 (C125G, p.Cys125Gly).
Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:
Change from medium size and polar (C) to glycine (G)
The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:
-3
The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another: Lowest score: -4 (low probability of substitution).Highest score: 11 (high probability of substitution). More information can be found on the following page
Variant description:
In PARK6; under depolarizing conditions, it fails to support PINK1-TOM-TIM23 complex assembly and mitophagy activation; no effect on interaction with TIMM23.
Any additional useful information about the variant.
Sequence information
Variant position:
125
The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:
581
The length of the canonical sequence.
Location on the sequence:
GLGLGLIEEKQAESRRAVSA
C QEIQAIFTQKSKPGPDPLDT
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:
The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human GLGLGLI-EEKQAESRRAVSAC QEIQAIFTQ-----KSKPGPDPLDT
Mouse GLGLGLI-EEKQAEGRRAASAC QEIQAIFTQ-----KTKRV
Rat GLGLGLI-EEKQAESRRAASAC QEIQAIFTQ-----KNKQV
Caenorhabditis elegans --------QPIRKELPRNVDLV ERIRQIFG------NSLRY
Drosophila ASGSGVLSKEDELEG-----VC WEIREAASRLQNAWNHDEI
Sequence annotation in neighborhood:
The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
Chain
78 – 581
Serine/threonine-protein kinase PINK1, mitochondrial
Topological domain
111 – 581
Cytoplasmic
Alternative sequence
1 – 307
Missing. In isoform 2.
Mutagenesis
131 – 131
I -> E. Under depolarizing conditions, it results in loss of interaction with TOMM20 and fails to support PINK1-TOM-TIM23 complex assembly and mitophagy activation.
Literature citations
TIM23 facilitates PINK1 activation by safeguarding against OMA1-mediated degradation in damaged mitochondria.
Akabane S.; Watanabe K.; Kosako H.; Yamashita S.I.; Nishino K.; Kato M.; Sekine S.; Kanki T.; Matsuda N.; Endo T.; Oka T.;
Cell Rep. 42:112454-112454(2023)
Cited for: INTERACTION WITH TIMM23; CHARACTERIZATION OF VARIANTS LEU-52; PHE-67; PRO-68; VAL-78; PHE-92; TRP-98; SER-111; LEU-115; VAL-124; GLY-125; PRO-126; MET-145; HIS-147; TRP-148; PRO-168; LYS-240; GLN-271; ASP-309; PRO-347; ALA-386; VAL-409; GLY-417 AND GLN-534 INS;
Tom20 gates PINK1 activity and mediates its tethering of the TOM and TIM23 translocases upon mitochondrial stress.
Eldeeb M.A.; Bayne A.N.; Fallahi A.; Goiran T.; MacDougall E.J.; Soumbasis A.; Zorca C.E.; Tabah J.J.; Thomas R.A.; Karpilovsky N.; Mathur M.; Durcan T.M.; Trempe J.F.; Fon E.A.;
Proc. Natl. Acad. Sci. U.S.A. 121:e2313540121-e2313540121(2024)
Cited for: INTERACTION WITH TOM AND TIM23 COMPLEXES; INTERACTION WITH TOMM20; MUTAGENESIS OF ILE-131; ALA-536; LEU-540 AND ARG-543; CHARACTERIZATION OF VARIANTS SER-111; LEU-115; GLY-125 AND PRO-126;
Mutational analysis of the PINK1 gene in early-onset parkinsonism in Europe and North Africa.
Ibanez P.; Lesage S.; Lohmann E.; Thobois S.; De Michele G.; Borg M.; Agid Y.; Durr A.; Brice A.;
Brain 129:686-694(2006)
Cited for: VARIANTS PARK6 GLY-125; LYS-240; PRO-369; ALA-386 AND VAL-409;
Disclaimer:
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.